Current role
Juan Carlos Jaen
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Juan Carlos Jaen
Arcus Biosciences, Inc. reported in an 8-K filed January 30, 2024 that Juan Carlos Jaen resigned as Board, effective January 29, 2024.
“On January 29, 2024 (i) Dr. Jaen and Ms. Jarrett resigned from the Board and (ii) following such resignations, the Board appointed Johanna Mercier to the Board as a Class II director.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Arcus Biosciences, Inc. (RCUS)
Proxy statement
CurrentStart not stated–present
-
Start not stated–2024-04-23
Last confirmed by a filing; no departure on record
-
Start not stated–2024-01-29
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Arcus Biosciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Terry Rosen CEO, Board Member
- Robert C. Goeltz II CFO, Chief Accounting Officer
- Robert Goeltz CFO
- Jennifer Jarrett COO
- Carolyn Tang General Counsel
- Alexander Azoy Chief Accounting Officer
- Andrew Perlman Board Member
- Andrew Perlman, MD, Ph.D. Board Member
- Antoni Ribas Board Member
- David L. Lacey, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.